Watch our latest episode of #OptimumTV⬇️ https://t.co/nzt4nzPKzy Paulo Neves, Chief Medical Officer of @Xeltis, discusses the company’s recent announcement of successful clinical data from its EU pivotal trial of aXess, its restorative vascular access conduit. Xeltis is

Online pharmacies and the arrival of GLP-1 #weightloss drugs have resulted in the emergence of a powerful new trend: people ‘self-paying’ for prescription drugs. What is the opportunity for #pharma companies and what happens from here? Read our insightful weekly #HotTopic here ⬇️

It’s been an incredible few days at @Jefferies & London Life Science Week #LLSW – and just around the corner is @OneNucleus's #Genesis Conference. Will we see you there? This week’s ‘Round-up’ includes huge #fundraisings, #patentapprovals, #award winners and a rallying cry to

The recent closing of two major life science funds from leading European VCs @medicxi and @SofinnovaVC Partners, together totalling more than €1 billion, bodes well for 2026. Read our latest #HotTopic here ⬇️ https://t.co/SVyNXqVDD9 #lifescience #investment

With London Life Sciences Week almost upon us, we have teamed up with @Catalyst Advisors to help you make the most of all the events – download the full guide in Optimum’s #WeeklyNewsletter below ⬇️ #HealthcareCommunications https://t.co/TlqWq63Y2T #Londonlifescienceweek #LLSW

Big ideas, bold moves, and biotech breakthroughs: it has been a busy week for Optimum and its clients - https://t.co/nLemQrEKDE 📺 Watch Healthcare Investor Conference panel highlights on Optimum TV 🧬 Exciting news from @OnaTherapeutics #Actithera & @MISSIONTherapeu 🔥 Hot

🚀 Insights, Innovation & Impact — That’s a Wrap on Optimum’s 2025 Conference! Read more: https://t.co/8KJLWiBRZE From groundbreaking fireside chats, to expert panels tackling the toughest challenges in life sciences, #OptimumConference2025 delivered a day full of actionable

📺 Countdown to Conference – Ep. 3 In the lead-up to Optimum’s 17th Annual Healthcare Investor Conference on October 9th in London, we speak with Antoine Papiernik, Chairman and Managing Partner at @SofinnovaVC. Antoine shares his optimistic view of the healthcare investment

✈️ A flying visit to Novo Holdings HQ in Copenhagen for the annual Seed Summit — a brilliant way to round off the week! Inspiring discussions on the future of the life sciences sector, the latest industry trends, and the growing impact of #AI made for a thought-provoking event.

While there’s a huge amount of interest in how #AI could help find new drugs to cure diseases, proven success in this field remains some way off. However, other applications of AI are having a real impact at the coalface of #healthcare right now. Read our latest #HotTopic to

It’s been an A* week! Advancements, acquisitions, appointments and Series A financings! Plus #OptimumTV dropped another #CountdowntoConference episode with the seasoned life science investor Søren Møller, Managing Partner of Novo Holdings Seed Investment. ⬇️

In the second of our Countdown to Conferenceseries – ahead of Optimum’s 17th Annual Healthcare Investor Conference being held on Thursday October 9th at The King’s Fund in London - we talk to seasoned life science investor Søren Møller, Managing Partner of @novoholdings Seed

Merck’s decision to scrap a £1bn research facility in London is a devastating blow to the UK’s plans to encourage growth by fostering R&D investment from #lifescience companies. Ministers face a major dilemma over how to encourage investment from #pharma without blowing the #NHS

Everyone knows the financing environment is tough right now. But that hasn’t stopped @SpliceBioHQ securing $135m in a Series B to advance its genetic medicines, including its lead programme SB-007 for the eye condition #Stargardt disease. Watch Miquel Vila- Perelló talk to